Divestiture

Unilever’s sale of Welly to Forward Consumer Partners signals a massive shift in how private equity capitalizes on corporate carve-outs in 2026.

After a five-year standoff and two proxy battles, ZimCal Asset Management secures a discounted debt buyout, allowing Medallion Financial to optimize its balance sheet.

As global diesel inventories hit decade lows, a structural refining bottleneck is minting billions for energy majors while threatening global supply chains.

Hudson Pacific Properties offloads a vacant San Jose campus and a Hollywood studio asset, signaling a ruthless recalibration of the West Coast innovation economy.

As Waldencast deregisters from the SEC and retreats to the OTC markets, the move exposes the harsh reality of indie beauty brands struggling in the public eye.

A Luxembourg judge has lifted the injunction blocking the sale of Ardagh Metal Packaging, clearing the runway for a massive industry restructuring.

As Christian Dior posts a mere 1% Q3 organic growth, a deep dive reveals how shedding assets and shifting focus are the new playbook for luxury survival.

As Ingevity prepares for its Q3 earnings, the specialty chemicals producer offers a pragmatic look into the future of automotive and infrastructure markets.

As Carbon Streaming shrinks its portfolio and hoards cash, a bitter legal feud over alleged financial misconduct highlights the shifting ESG landscape.

Neogen's Q1 results show promise with raised guidance, but debt, transition costs, and a new FDA warning reveal a steep climb ahead for the company.

Tradr ETFs is shuttering five niche leveraged funds. For day traders and market analysts, it is a stark warning about the brutal math of volatility decay.

By divesting its CTH casings unit to SARIA, Darling Ingredients is pruning its legacy assets to fund the renewable energy networks powering tomorrow's cities.

A Nasdaq deficiency notice puts ATA Creativity Global on the clock. Can the Chinese edtech firm survive its radical restructuring and avoid delisting?

American Bancorp sold New Republic Bank just 11 months after acquiring it. Beneath the surface, it’s a masterclass in strategic carving and footprint focus.

Clariant’s involuntary sale of its Stahl stake yields a CHF 220 million cash injection, paving the way for targeted growth and industry consolidation.

Radnostix divests its stalled New Mexico nuclear fuel assets to NANO Nuclear for $13.5 million, marking a high-stakes pivot toward medical theranostics.

Behind a routine M&A announcement lies a brilliant strategic play. Why INNIO is betting big on the lucrative APAC aftermarket.

By offloading its capital-heavy rental unit to Rotech, Inogen is rewriting its business model to focus on high-margin respiratory innovation and scale.

Alta Development is selling its mid-construction luxury student housing tower, SoMi Walk, testing institutional appetite in a supply-constrained market.

Arco Vara executes a masterclass in regional consolidation, utilizing a self-financed management buyout to exit Bulgaria and fund Tallinn megaprojects.